Tag: Priority review

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Priority review

IQ-AI says Imaging Biometrics submits paediatric rare disease request - Morningstar

Added to Collection on: 2023-11-08 12:28:11

Tags for this article:

Gallium compounds
Food and Drug Administration
Priority review
Gallium maltolate
Gallium
Imaging Biometrics LLC

Click the tags to see associated articles and topics

View Article Details
Pharma Stock Roundup: FDA Priority Tag to SNY, ABBV Filings, CHMP Nod for AZN, JNJ, MRK

Added to Collection on: 2024-02-29 15:39:58

Tags for this article:

Orphan drugs
Antineoplastic drugs
Food and Drug Administration
Priority review
Dupilumab
AbbVie
Pembrolizumab
Sanofi
Regeneron Pharmaceuticals
Pharmaceutical industry
Genmab
European Medicines Agency

Click the tags to see associated articles and topics

View Article Details
IQ-AI subsidiary gets second FDA rare paediatric disease designation - Share Prices

Added to Collection on: 2024-05-20 22:21:09

Tags for this article:

Food and Drug Administration
Priority review
Atypical teratoid rhabdoid tumor
Artificial intelligence
Alliance News Ltd.
LONDON
Imaging Biometrics LLC

Click the tags to see associated articles and topics

View Article Details
FDA Activity Recap: June 2024 Features Expanded Indication Approval, a CRL, RMAT ...

Added to Collection on: 2024-07-06 17:15:14

Tags for this article:

Food and Drug Administration
Biotechnology
Pharmaceuticals policy
Pharmacy
Regenerative Medicine Advanced Therapy
Applied genetics
Sarepta Therapeutics
Gene therapy
Duchenne muscular dystrophy
Delandistrogene moxeparvovec
Priority review
Therapy

Click the tags to see associated articles and topics

View Article Details
Earnings call: Ultragenyx reports strong Q2 revenue, raises guidance - Investing.com

Added to Collection on: 2024-08-04 18:38:57

Tags for this article:

Ultragenyx
Emil Kakkis
Orphan drugs
Priority review
Vestronidase alfa
Angelman syndrome
Ultragenyx Pharmaceutical Inc
Joshua Higa

Click the tags to see associated articles and topics

View Article Details
Neurogene Inc. Announces RMAT Designation for NGN-401 Investigational Gene Therapy ...

Added to Collection on: 2024-08-07 21:20:42

Tags for this article:

Food and Drug Administration
Pharmacy
Pharmaceuticals policy
Regenerative Medicine Advanced Therapy
Priority review
Breakthrough therapy
Fast track
Accelerated approval
Clinical trial
Gene therapy
Helixmith
Neurogene Inc.
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Humacyte Announces FDA Communication of Additional Time Required to Complete ... - Stock Titan

Added to Collection on: 2024-08-10 08:17:50

Tags for this article:

Food and Drug Administration
Prescription Drug User Fee Act
PDUFA date
Priority review
Biologics license application
humacyte, inc.
Ukraine

Click the tags to see associated articles and topics

View Article Details
Opus Genetics Receives Rare Pediatric Disease Designation from the U.S. FDA for Ocular ...

Added to Collection on: 2024-08-20 18:06:53

Tags for this article:

Gene delivery
Medical genetics
Molecular biology
Rare diseases
Blindness
Foundation Fighting Blindness
Gene therapy
Leber congenital amaurosis
Gene therapy of the human retina
Priority review
Retina
Voretigene neparvovec

Click the tags to see associated articles and topics

View Article Details
Neuren Pharmaceuticals (ASX:NEU): Another exciting chapter is yet to come with NNZ-2591

Added to Collection on: 2024-09-24 20:11:05

Tags for this article:

Orphan drugs
Trofinetide
Acadia Pharmaceuticals
NNZ-2591
Priority review
Food and Drug Administration
Royalty payment
Neuren Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Pharma Stock Roundup: FDA Approves SNY's Dupixent for COPD & More - October 4, 2024

Added to Collection on: 2024-10-05 06:31:20

Tags for this article:

Antineoplastic drugs
Orphan drugs
Antibody-drug conjugates
Immunology
Cancer treatments
Trastuzumab deruxtecan
Sanofi
Regeneron Pharmaceuticals
Antibody-drug conjugate
Priority review
HER2
Dupilumab

Click the tags to see associated articles and topics

View Article Details